NCT03830359已完成不适用
Efficacy and Safety Assessment of T2769 in Patients With Moderate to Severe Dry Eye Syndrome
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 62
- 试验地点
- 5
- 主要终点
- Ocular Symptomatology
研究概览
简要总结
Efficacy of T2769 in Dry Eye Desease
详细描述
Multicenter and open study
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Signed and dated informed consent
- •Male or female aged from ≥ 18 years old
- •Known Dry Eye Syndrome requiring artificial tears within the last 3 months prior to study screening
排除标准
- •Best far corrected visual acuity ≤ 2/10
- •Severe blepharitis Severe dry eye
结局指标
主要结局
Ocular Symptomatology
时间窗: Baseline and Day 42
Change from baseline in ocular symptomatology on a Visual Analog Scale (0=No discomfort and 100=Maximal discomfort) at Day 42.
次要结局
未报告次要终点
研究者
研究点 (5)
Loading locations...
相似试验
已完成
不适用
Performance and Safety of T2769 in DEDDry EyeNCT05965778Laboratoires Thea251
已完成
2 期
Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry EyeGraft vs. Host DiseaseDry EyeSjogren's SyndromeNCT01393132Michigan Cornea Consultants, PC9
已完成
4 期
Efficacy and Safety of a Treatment for Dry Eye Syndrome: ThealozModerate Dry Eye SyndromeNCT01742884Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA50
已完成
3 期
Study to Evaluate the Efficacy and Safety of CKD-352Dry Eye DiseaseNCT04548427Chong Kun Dang Pharmaceutical283
已完成
4 期
The DEPOT Study (Dry Eye Prescription Options for Therapy)Dry EyeNCT04911361Research Insight LLC50